{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:21:53Z","timestamp":1785414113851,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.amjmed.2021.10.020","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T10:47:23Z","timestamp":1636973243000},"page":"471-477.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prior Exposure to Nonsteroidal Anti-inflammatory Drugs Reduces the Rate of Organ Failure and In-Hospital Mortality in Acute Pancreatitis"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8013-3545","authenticated-orcid":false,"given":"Antonio Mendoza","family":"Ladd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darwin","family":"Conwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munigala","family":"Satish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjmed.2021.10.020_bib0001","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.amjmed.2021.10.020_bib0002","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/bjs.5290","article-title":"Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis","volume":"93","author":"Mofidi","year":"2006","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.amjmed.2021.10.020_bib0003","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2215\/CJN.13191118","article-title":"AKI associated with acute pancreatitis","volume":"14","author":"Nassar","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2021.10.020_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6089430","article-title":"Aspirin protects against acinar cells necrosis in severe acute pancreatitis in mice","volume":"2016","author":"Lu","year":"2016","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.amjmed.2021.10.020_bib0005","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.shk.0000192122.91166.a8","article-title":"Influence of nitric oxide-donating nonsteroidal anti-inflammatory drugs on the evolution of acute pancreatitis","volume":"25","author":"Cosen-Binker","year":"2006","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.amjmed.2021.10.020_bib0006","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/S1807-59322006000400005","article-title":"Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis","volume":"61","author":"de Almeida","year":"2006","journal-title":"Clinics (Sao Paulo)"},{"issue":"16","key":"10.1016\/j.amjmed.2021.10.020_bib0007","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v13.i16.2298","article-title":"Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats","volume":"13","author":"Seo","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"19","key":"10.1016\/j.amjmed.2021.10.020_bib0008","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.3748\/wjg.v19.i19.2894","article-title":"Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats","volume":"19","author":"Akyazi","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjmed.2021.10.020_bib0009","doi-asserted-by":"crossref","first-page":"473","DOI":"10.14309\/ajg.0000000000000529","article-title":"Prevention of severe acute pancreatitis with cyclooxygenase-2 inhibitors: a randomized controlled clinical trial","volume":"115","author":"Huang","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjmed.2021.10.020_bib0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archsurg.1974.01360020016004","article-title":"Experimental pancreatitis treated with glucagon or lactated Ringer solution","volume":"109","author":"Condon","year":"1974","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.amjmed.2021.10.020_bib0011","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.45.1.97","article-title":"A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis","volume":"45","author":"Uhl","year":"1999","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.amjmed.2021.10.020_bib0012","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1023\/A:1026679106463","article-title":"Octreotide treatment in patients with severe acute pancreatitis","volume":"45","author":"Paran","year":"2000","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.amjmed.2021.10.020_bib0013","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2036.1998.00295.x","article-title":"Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis","volume":"12","author":"Andriulli","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.amjmed.2021.10.020_bib0014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00006676-200405000-00003","article-title":"Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit","volume":"28","author":"Imaizumi","year":"2004","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.amjmed.2021.10.020_bib0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/1319-3767.80379","article-title":"Safety and efficacy of vitamin-based antioxidant therapy in patients with severe acute pancreatitis: a randomized controlled trial","volume":"17","author":"Bansal","year":"2011","journal-title":"Saudi J Gastroenterol"},{"issue":"10","key":"10.1016\/j.amjmed.2021.10.020_bib0016","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gut.2006.115873","article-title":"Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis","volume":"56","author":"Siriwardena","year":"2007","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.amjmed.2021.10.020_bib0017","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.bcp.2005.01.023","article-title":"Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant","volume":"69","author":"Leveau","year":"2005","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.amjmed.2021.10.020_bib0018","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02924441","article-title":"Protective effect of AA-861 (5-lipoxygenase inhibitor) on experimental acute necrotizing pancreatitis in rats","volume":"13","author":"Kiriyama","year":"1993","journal-title":"Int J Pancreatol"},{"issue":"1","key":"10.1016\/j.amjmed.2021.10.020_bib0019","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/gut.48.1.62","article-title":"Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organfailure in predicted severe acute pancreatitis","volume":"48","author":"Johnson","year":"2001","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.amjmed.2021.10.020_bib0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0344-0338(84)80009-6","article-title":"Experimental acute pancreatitis in dogs and effects of steroids. A light and electron microscopic study with reference to pathogenesis","volume":"178","author":"Imahori","year":"1984","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.amjmed.2021.10.020_bib0021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1572-0241.1998.061_c.x","article-title":"Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial","volume":"93","author":"Dumot","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.amjmed.2021.10.020_bib0022","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1023\/A:1011902729392","article-title":"Hydrocortisone treatment of early SIRS in acute experimental pancreatitis","volume":"46","author":"Gloor","year":"2001","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.amjmed.2021.10.020_bib0023","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.gastro.2015.04.019","article-title":"Pentoxifylline treatment in severe acute pancreatitis: a pilot, double-blind, placebo-controlled, randomized trial","volume":"149","author":"Vege","year":"2015","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.amjmed.2021.10.020_bib0024","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","article-title":"A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis","volume":"366","author":"Elmunzer","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2021.10.020_bib0025","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.gie.2017.01.033","article-title":"Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials","volume":"85","author":"Patai","year":"2017","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.amjmed.2021.10.020_bib0026","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MPA.0000000000000245","article-title":"Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis","volume":"44","author":"Nicol\u00e1s-P\u00e9rez","year":"2015","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.amjmed.2021.10.020_bib0027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00004836-200203000-00021","article-title":"Acute pancreatitis caused by ketorolac tromethamine","volume":"34","author":"Famularo","year":"2002","journal-title":"J Clin Gastroenterol"},{"issue":"812","key":"10.1016\/j.amjmed.2021.10.020_bib0028","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/pgmj.69.812.486","article-title":"Pancreatitis associated with diclofenac","volume":"69","author":"Khan","year":"1993","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.amjmed.2021.10.020_bib0029","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.mej.0000224428.51623.b2","article-title":"Acute pancreatitis following naproxen intake","volume":"13","author":"Aygencel","year":"2006","journal-title":"Eur J Emerg Med"},{"issue":"4","key":"10.1016\/j.amjmed.2021.10.020_bib0030","first-page":"344","article-title":"Indomethacin-induced pancreatitis: a case report","volume":"6","author":"Memis","year":"2005","journal-title":"JOP"},{"issue":"7","key":"10.1016\/j.amjmed.2021.10.020_bib0031","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3109\/00365528509088825","article-title":"Indomethacin treatment of acute pancreatitis. A controlled double-blind trial","volume":"20","author":"Ebbeh\u00f8j","year":"1985","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjmed.2021.10.020_bib0032","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000114852","article-title":"Efficacy and tolerance of metamizole versus morphine for acute pancreatitis pain","volume":"8","author":"Peir\u00f3","year":"2008","journal-title":"Pancreatology"},{"issue":"3","key":"10.1016\/j.amjmed.2021.10.020_bib0033","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1308\/rcsann.2017.0205","article-title":"The effect of non-steroidal anti-inflammatory drugs on severity of acute pancreatitis and pancreatic necrosis","volume":"100","author":"Baxter","year":"2018","journal-title":"Ann R Coll Surg Engl"},{"issue":"5174","key":"10.1016\/j.amjmed.2021.10.020_bib0034","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.amjmed.2021.10.020_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/187152806776383125","article-title":"Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation","volume":"5","author":"Parkinson","year":"2006","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"21","key":"10.1016\/j.amjmed.2021.10.020_bib0036","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Cl\u00e0ria","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.amjmed.2021.10.020_bib0037","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1590\/S0100-879X2001000500002","article-title":"Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins","volume":"34","author":"Fierro","year":"2001","journal-title":"Braz J Med Biol Res"},{"issue":"3-4","key":"10.1016\/j.amjmed.2021.10.020_bib0038","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution","volume":"73","author":"Serhan","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"10.1016\/j.amjmed.2021.10.020_bib0039","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321007324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321007324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:27:00Z","timestamp":1757582820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934321007324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0002934321007324"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.10.020","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prior Exposure to Nonsteroidal Anti-inflammatory Drugs Reduces the Rate of Organ Failure and In-Hospital Mortality in Acute Pancreatitis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}